Nuvalent Inc (NUVL)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
James R. Porter
Employees:
40
ONE BROADWAY, 14TH FLOOR, CAMBRIDGE, MA 02142
508-446-2272

Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations.

Data derived from most recent annual or quarterly report
Market Cap 2.179 Billion Shares Outstanding51.269 Million Avg 30-day Volume 241.258 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-1.73
Price to Revenue0.0 Debt to Equity0.0 EBITDA-101.817 Million
Price to Book Value3.3323 Operating Margin0.0 Enterprise Value1.029 Billion
Current Ratio26.808 EPS Growth-4.966 Quick Ratio26.465
1 Yr BETA 1.5708 52-week High/Low 43.6 / 8.12 Profit Margin0.0
Operating Cash Flow Growth-59.3039 Altman Z-Score52.0246 Free Cash Flow to Firm -61.67 Million
Earnings Report2023-08-09
View SEC Filings from NUVL instead.

View recent insider trading info

Funds Holding NUVL (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NUVL

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2023-05-11:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-16:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-13:
    Item 7.01: Regulation FD Disclosure
  • 8-K: filed on 2022-11-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-01:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 1.01: Entry into a Material Definitive Agreement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-10-28:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-10-06:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-08-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    15 Thousand total shares from 14 transactions

    Exercise Derivative Conversion (M)

    15 Thousand total shares from 7 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    MILLER DEBORAH ANN CHIEF LEGAL OFFICER

    • Officer
    0 2023-05-15 11

    NOCI DARLENE CHIEF DEVELOPMENT OFFICER

    • Officer
    0 2023-05-01 15

    TURNER CHRISTOPHER DURANT CHIEF MEDICAL OFFICER

    • Officer
    144,200 2023-01-06 1

    BALCOM ALEXANDRA CHIEF FINANCIAL OFFICER

    • Officer
    144,200 2023-01-06 1

    PORTER JAMES RICHARD PRESIDENT AND CEO

    • Officer
    • Director
    420,780 2023-01-06 1

    SHAIR MATTHEW

    • Director
    2,185,220 2023-01-04 7

    FLYNN JAMES E

    DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

    DEERFIELD MGMT HIF, L.P.

    DEERFIELD HEALTHCARE INNOVATIONS FUND, L.P.

    DEERFIELD PARTNERS, L.P.

    DEERFIELD MGMT L.P.

    DEERFIELD MGMT IV, L.P.

    DEERFIELD PRIVATE DESIGN FUND IV, L.P.

    • Director
    • 10% Owner
    • DIRECTOR BY DEPUTIZATION* DIRECTOR BY DEPUTIZATION* DIRECTOR BY DEPUTIZATION* DIRECTOR BY DEPUTIZATION* DIRECTOR BY DEPUTIZATION* DIRECTOR BY DEPUTIZATION* DIRECTOR BY DEPUTIZATION* DIRECTOR BY DEPUTIZATION
    10,320,512 2022-11-03 2

    DEERFIELD PARTNERS, L.P.

    • Director
    • 10% Owner
    • DIRECTOR BY DEPUTIZATION
    650,000 2022-11-03 1

    HACK ANDREW A. F.

    • Director
    3,577,267 2022-11-03 2

    MEYERS MICHAEL L.

    • Director
    0 2022-10-04 2

    FLYNN JAMES E

    DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

    • Director
    • 10% Owner
    • DIRECTOR BY DEPUTIZATIONDIRECTOR BY DEPUTIZATION
    20,000 2022-06-16 2

    PROTOPAPAS ANNA

    • Director
    20,000 2022-06-16 1

    SRIVASTAVA SAPNA

    • Director
    20,000 2022-06-16 1

    GILLILAND DWIGHT GARY

    • Director
    20,000 2022-06-16 1

    WHEELER CAMERON

    • Director
    20,000 2022-06-16 1

    PEARLBERG JOSEPH

    • Director
    20,000 2022-06-16 1

    CONLEY EMILY

    • Director
    20,000 2022-06-16 1

    FLYNN JAMES E

    DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

    DEERFIELD MGMT HIF, L.P.

    DEERFIELD HEALTHCARE INNOVATIONS FUND, L.P.

    DEERFIELD MGMT IV, L.P.

    DEERFIELD PRIVATE DESIGN FUND IV, L.P.

    • Director
    • 10% Owner
    • DIRECTOR BY DEPUTIZATIONDIRECTOR BY DEPUTIZATIONDIRECTOR BY DEPUTIZATIONDIRECTOR BY DEPUTIZATIONDIRECTOR BY DEPUTIZATIONDIRECTOR BY DEPUTIZATION
    28,113,862 2021-08-02 2

    FAZZOLARI SALVATORE D

    • Director
    202,270 2016-12-01 0

    CARLSON DAVID C. CHIEF FINANCIAL OFFICER

    • Officer
    62,395 2016-12-01 0

    DAVENPORT COLLEEN M. GENERAL COUNSEL & SECRETARY

    • Officer
    3,910 2016-12-01 0

    MILLER DONALD

    • Director
    • 10% Owner
    19,279 2016-12-01 0

    MANDEL JAMES PRESIDENT & CEO

    • Officer
    • Director
    • 10% Owner
    298,520 2016-12-01 0

    DODGE JONATHAN

    • Director
    4,692 2016-12-01 0

    HATTARA JEFFREY J. CHIEF STRATEGY OFFICER

    • Officer
    • Director
    • 10% Owner
    34,481 2016-12-01 0

    PEYTON WHITNEY E.

    • Director
    • 10% Owner
    148,625 2016-12-01 0

    BATCHELOR DAVID W. CHIEF RELATIONS OFFICER

    • Officer
    • Director
    • 10% Owner
    42,473 2016-12-01 0

    RESNICK RICHARD P. EXECUTIVE VP OF OPERATIONS

    • Officer
    • Director
    9,022,069 2016-12-01 0

    RIESS ROBERT F. COO & CMO

    • Officer
    • Director
    6,983 2016-12-01 0

    PHILBIN ROBERT J.

    • CEO & BOARD CHAIR - AGILIVANT
    5,865 2016-12-01 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    MILLER DEBORAH ANN - Officer CHIEF LEGAL OFFICER

    2023-05-17 16:44:17 -0400 2023-05-15 M 2,000 d 206,138 direct yes

    MILLER DEBORAH ANN - Officer CHIEF LEGAL OFFICER

    2023-05-17 16:44:17 -0400 2023-05-15 M 2,000 $6.89 a 2,000 direct yes 0.2826 -0.6423 4.7276 3 -0.6423 6

    MILLER DEBORAH ANN - Officer CHIEF LEGAL OFFICER

    2023-05-17 16:44:17 -0400 2023-05-15 S 1,498 $40.89 d 0 direct yes 0.2826 -0.6423 4.7276 3 -0.6423 6

    MILLER DEBORAH ANN - Officer CHIEF LEGAL OFFICER

    2023-05-17 16:44:17 -0400 2023-05-15 S 502 $40.31 d 1,498 direct yes 0.2826 -0.6423 4.7276 3 -0.6423 6

    MILLER DEBORAH ANN - Officer CHIEF LEGAL OFFICER

    2023-05-09 17:11:03 -0400 2023-05-09 M 1,332 d 208,138 direct yes

    MILLER DEBORAH ANN - Officer CHIEF LEGAL OFFICER

    2023-05-09 17:11:03 -0400 2023-05-09 S 1,332 $39.63 d 0 direct yes -0.7428 -2.2035 0.8666 4 -2.4511 3

    MILLER DEBORAH ANN - Officer CHIEF LEGAL OFFICER

    2023-05-09 17:11:03 -0400 2023-05-09 M 1,332 $6.89 a 1,332 direct yes -0.7428 -2.2035 0.8666 4 -2.4511 3

    MILLER DEBORAH ANN - Officer CHIEF LEGAL OFFICER

    2023-05-09 17:11:03 -0400 2023-05-05 M 2,800 d 209,470 direct yes

    MILLER DEBORAH ANN - Officer CHIEF LEGAL OFFICER

    2023-05-09 17:11:03 -0400 2023-05-05 S 2,800 $39.64 d 0 direct yes -0.7428 -2.2035 0.8666 4 -2.4511 3

    MILLER DEBORAH ANN - Officer CHIEF LEGAL OFFICER

    2023-05-09 17:11:03 -0400 2023-05-05 M 2,800 $6.89 a 2,800 direct yes -0.7428 -2.2035 0.8666 4 -2.4511 3

    NOCI DARLENE - Officer CHIEF DEVELOPMENT OFFICER

    2023-05-03 16:41:00 -0400 2023-05-01 M 3,000 d 111,389 direct yes

    MILLER DEBORAH ANN - Officer CHIEF LEGAL OFFICER

    2023-05-03 16:38:10 -0400 2023-05-01 M 900 d 212,270 direct yes

    MILLER DEBORAH ANN - Officer CHIEF LEGAL OFFICER

    2023-05-03 16:38:10 -0400 2023-05-01 S 900 $39.61 d 0 direct yes -0.491 3.5917 4.3669 5 -2.4289 3

    MILLER DEBORAH ANN - Officer CHIEF LEGAL OFFICER

    2023-05-03 16:38:10 -0400 2023-05-01 M 900 $6.89 a 900 direct yes -0.491 3.5917 4.3669 5 -2.4289 3

    NOCI DARLENE - Officer CHIEF DEVELOPMENT OFFICER

    2023-05-03 16:41:00 -0400 2023-05-01 M 3,000 $1.08 a 3,000 direct yes -0.491 3.5917 4.3669 5 -2.4289 3

    NOCI DARLENE - Officer CHIEF DEVELOPMENT OFFICER

    2023-05-03 16:41:00 -0400 2023-05-01 S 2,282 $38.81 d 50 direct yes -0.491 3.5917 4.3669 5 -2.4289 3

    NOCI DARLENE - Officer CHIEF DEVELOPMENT OFFICER

    2023-05-03 16:41:00 -0400 2023-05-01 S 549 $38.03 d 2,332 direct yes -0.491 3.5917 4.3669 5 -2.4289 3

    NOCI DARLENE - Officer CHIEF DEVELOPMENT OFFICER

    2023-05-03 16:41:00 -0400 2023-05-01 S 91 $36.98 d 2,881 direct yes -0.491 3.5917 4.3669 5 -2.4289 3

    NOCI DARLENE - Officer CHIEF DEVELOPMENT OFFICER

    2023-05-03 16:41:00 -0400 2023-05-01 S 50 $39.58 d 0 direct yes -0.491 3.5917 4.3669 5 -2.4289 3

    NOCI DARLENE - Officer CHIEF DEVELOPMENT OFFICER

    2023-05-03 16:41:00 -0400 2023-05-01 S 28 $35.71 d 2,972 direct yes -0.491 3.5917 4.3669 5 -2.4289 3

    MILLER DEBORAH ANN - Officer CHIEF LEGAL OFFICER

    2023-04-19 16:46:47 -0400 2023-04-17 M 2,000 d 213,170 direct yes

    MILLER DEBORAH ANN - Officer CHIEF LEGAL OFFICER

    2023-04-19 16:46:47 -0400 2023-04-17 M 2,000 $6.89 a 2,000 direct yes 2.9201 2.354 5.1847 4 0.0 1

    MILLER DEBORAH ANN - Officer CHIEF LEGAL OFFICER

    2023-04-19 16:46:47 -0400 2023-04-17 S 1,875 $30.15 d 0 direct yes 2.9201 2.354 5.1847 4 0.0 1

    MILLER DEBORAH ANN - Officer CHIEF LEGAL OFFICER

    2023-04-19 16:46:47 -0400 2023-04-17 S 125 $29.33 d 1,875 direct yes 2.9201 2.354 5.1847 4 0.0 1

    NOCI DARLENE - Officer CHIEF DEVELOPMENT OFFICER

    2023-04-05 16:40:40 -0400 2023-04-03 S 112 $27.06 d 0 direct yes 7.9245 18.826 63.6478 70.8176 27 0.0 1

    NOCI DARLENE - Officer CHIEF DEVELOPMENT OFFICER

    2023-04-05 16:40:40 -0400 2023-04-03 M 3,000 d 114,389 direct yes

    NOCI DARLENE - Officer CHIEF DEVELOPMENT OFFICER

    2023-04-05 16:40:40 -0400 2023-04-03 M 3,000 $1.08 a 3,000 direct yes 7.9245 18.826 63.6478 70.8176 27 0.0 1

    NOCI DARLENE - Officer CHIEF DEVELOPMENT OFFICER

    2023-04-05 16:40:40 -0400 2023-04-03 S 2,888 $26.57 d 112 direct yes 7.9245 18.826 63.6478 70.8176 27 0.0 1

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    NUVALENT INC-A NUVL 2023-06-02 13:15:04 UTC 4.6799 0.3901 500000
    NUVALENT INC-A NUVL 2023-06-02 12:45:03 UTC 4.6799 0.3901 500000
    NUVALENT INC-A NUVL 2023-06-01 22:15:04 UTC 4.6578 0.4122 500000
    NUVALENT INC-A NUVL 2023-06-01 21:45:04 UTC 4.6578 0.4122 500000
    NUVALENT INC-A NUVL 2023-06-01 21:15:05 UTC 4.6578 0.4122 500000
    NUVALENT INC-A NUVL 2023-06-01 20:45:03 UTC 4.6578 0.4122 500000
    NUVALENT INC-A NUVL 2023-06-01 20:15:04 UTC 4.645 0.425 500000
    NUVALENT INC-A NUVL 2023-06-01 19:45:03 UTC 4.645 0.425 500000
    NUVALENT INC-A NUVL 2023-06-01 19:15:04 UTC 4.645 0.425 200000
    NUVALENT INC-A NUVL 2023-06-01 18:45:03 UTC 4.6986 0.3714 200000
    NUVALENT INC-A NUVL 2023-06-01 18:15:04 UTC 4.6986 0.3714 500000
    NUVALENT INC-A NUVL 2023-06-01 17:45:04 UTC 4.6986 0.3714 500000
    NUVALENT INC-A NUVL 2023-06-01 17:15:04 UTC 4.6986 0.3714 200000
    NUVALENT INC-A NUVL 2023-06-01 16:45:04 UTC 4.6886 0.3714 200000
    NUVALENT INC-A NUVL 2023-06-01 16:15:04 UTC 4.6886 0.3714 200000
    NUVALENT INC-A NUVL 2023-06-01 15:45:03 UTC 4.6886 0.3714 200000
    NUVALENT INC-A NUVL 2023-06-01 15:15:04 UTC 4.6886 0.3714 500000
    NUVALENT INC-A NUVL 2023-06-01 14:45:04 UTC 4.6886 0.3714 500000
    NUVALENT INC-A NUVL 2023-06-01 14:15:04 UTC 4.6886 0.3714 200000
    NUVALENT INC-A NUVL 2023-06-01 13:45:04 UTC 4.7433 0.3167 200000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund NUVL -1600.0 shares, $-41744.0 2023-03-31 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments